ArticlePharmaceutics2020

Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment.

Vineela Parvathaneni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.